✦ LIBER ✦

A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

Book ID: 117659629
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 139 KB
Volume: 38
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)80937-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histone Deacetylase Inhibitors: Developm

Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of Cancers

✍ Victoria M. Richon; Xianbo Zhou; Richard A. Rifkind; Paul A. Marks 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Tu1214 The Histone Deacetylase Inhibitor

Tu1214 The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Differentiation of Intestinal Cells

✍ Roostaee, Alireza; Benoit, Yannick D.; Guezguez, Amel; Simoneau, Aline; Beaulieu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Suppressive effect of the histone deacet

Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication

✍ Sato, Ayami; Saito, Yoshimasa; Sugiyama, Kazuo; Sakasegawa, Noriko; Muramatsu, T 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Histone deacetylase inhibitor, suberoyla

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

✍ Takashi Kumagai; Naoki Wakimoto; Dong Yin; Sigal Gery; Norihiko Kawamata; Noriyu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB 👁 1 views

## Abstract Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated by histone deacetylase (HDAC). HDAC inhibitors can block cancer cell growth by restoring expression of tumor suppressor genes. In th

Phase 1 study of the histone deacetylase

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

✍ Garcia-Manero, G.; Yang, H.; Bueso-Ramos, C.; Ferrajoli, A.; Cortes, J.; Wierda, 📂 Article 📅 2008 🏛 American Society of Hematology 🌐 English ⚖ 795 KB

In vivo redox state of Human thioredoxin

In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

✍ J. Ungerstedt; Y. Du; H. Zhang; D. Nair; A. Holmgren 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 622 KB